About ALVUS HEALTH INC.
Alvus Health enables patient-derived epithelial organoids for high-throughput, multi-modal phenotypic profiling, revolutionizing biopharmaceutical discovery with AI. They partnered with NASA, MGH, and SpaceTango to send organoids to space in March 2024.
Patient-derived epithelial organoid developmentHigh-throughput, multi-modal phenotypic profilingIntegration with high-throughput automation and AI-enabled analysisOrganoid culturing with 2.5D model combining benefits of cell lines and 3D organoidsMultiplex staining and sequencing for single-cell level molecular profiling
Is this your company?
Claim ALVUS HEALTH INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ALVUS HEALTH INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.